Loss of heterozygosity analysis of a candidate gastric carcinoma tumor suppressor locus at 7q31

Cancer Genetics and Cytogenetics

Volumn 166, Issue 2, 2006, Pages 166-172

  Xia, Jian Chuan ^a   Weng, De Sheng ^a   Li, Jin Tian ^a   Qin, Hai De ^a   Mai, Shi Juan ^a   Feng, Bing Jian ^a   Fan, Qin ^a   Feng, Qi Sheng ^a   Huang, Li Xi ^a   Yu, Xing Juan ^a   Pan, Zhi Zhong ^a   Li, Yong Qiang ^a   Wang, Qi Jing ^a   Zhan, You Qing ^a   Chen, Shi Ping ^a   He, Jia ^a   Huang, Wen lin ^a   Wu, Pei Hong ^a   Zeng, Yi Xing ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME 7Q; CHROMOSOME DELETION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE DELETION; GENE LOCUS; GENOTYPE; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PHYSICAL CHROMOSOME MAPPING; STOMACH NEOPLASMS;

EID: 33646042562     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.11.005     Document Type: Article

References (38)

1. Kasakura Y., Phan A., and Ajani J. Adjuvant therapy for resected gastric carcinoma. Surg Oncol Clin N Am 11 (2002) 431-444
2. El-Rrifai W., Harper J.C., Cummings O.W., Hyytinen E.R., Frierson Jr. H.F., Knuutila S., and Powell S.M. Consistent genetic alterations in xenografts of proximal stomach and gastro-esophageal junction adenocarcinomas. Cancer Res 58 (1998) 34-37
3. Yustein A.S., Harper J.C., Petroni G.R., Cummings O.W., Moskaluk C.A., and Powell S.M. Allelotype of gastric adenocarcinoma. Cancer Res 59 (1999) 1437-1441
4. Nishizuka S., Tamura G., Terashima M., and Satodate R. Loss of heterozygosity during the development and progression of differentiated adenocarcinoma of the stomach. J Pathol 185 (1998) 38-43
5. Li B.C., Chan W.Y., Li C.Y., Chow C., Ng E.K., and Chung S.C. Allelic loss of chromosome 6q in gastric carcinoma. Diagn Mol Pathol 12 (2003) 193-200
6. Sugai T., Habano W., Uesugi N., Jao Y.F., Nakamura S., Abe K., Takagane A., and Terashima M. Three independent genetic profiles based on mucin expression in early differentiated-type gastric cancers-a new concept of genetic carcinogenesis of early differentiated-type adenocarcinomas. Mod Pathol 17 (2004) 1223-1234
7. Xia J.C., Lu S., Geng J.S., Fu S.B., Li P., and Liu Q.Z. Direct chromosome analysis of ten primary gastric cancer. Cancer Genet Cytogent 102 (1998) 88-90
8. Xiao S., Geng J.S., Feng X.L., Liu X.Q., Liu Q.Z., and Li P. Cytogenetic studies of eight primary gastric cancers. Cancer Genet Cytogenet 58 (1992) 79-84
9. Jianchuan X., Song L., Jianhua Z., Xiaoming N., Quanzhang L., and Pu L. Detection of chromosome aberrations in twelve primary gastric cancers by direct chromosome analysis and FISH. Chin Med Sci J 14 (1999) 7-12
10. Latil A., Cussenot O., Fournier G., Baron J.C., and Lidereau R. Loss of hetrozygosity at 7q31 is a frequent and early event in prostate cancer. Clin Cancer Res 1 (1995) 1385-1389
11. Gorgoulis V.G., Mariatos G., Manolis E.N., Zacharatos P., Kotsinas A., Liloglou T., Vogiatzi T., Tsagkaraki A., Kokotas S., Tsoli E., Alchanatis M., Sfikakis P.P., Asimacopoulos P.J., Field J.K., and Kittas C. Allelic imbalance at the 5q14 locus is associated with decreased apoptotic rate in non-small cell lung carcinomas (NSCLCs). Possible synergistic effect with p53 gene alterations on apoptosis. Lung Cancer 28 (2000) 211-224
12. Antoine V., Gaelle F., Wael S., Azzouzi R., Dey J., Chantrel-Groussard K., Latil A., Berthon P., Cussenot O., Pontes J.E., and Cher M.L. High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy. Urologic Oncol 23 (2005) 87-92
13. Luna-Fineman S., Shannon K.M., and Lange B.J. Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood 85 (1995) 1985-1999
14. Fischer K., Frohling S., Scherer S.W., McAllister B.J., Scholl C., Stilgenbauer S., Tsui L.C., Lichter P., and Dohner H. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood 89 (1997) 2036-2041
15. Tosi S., Scherer S.W., Giudici G., Czepulkowski B., Biondi A., and Kearney L. Delineation of multiple deleted regions in 7q in myeloid disorders. Genes Chromosomes Cancer 25 (1999) 384-392
16. Belen M.G., Norma C.G., Juan L., Schoenmakers E.F., Sole F., Calasanz M.J., San Miguel J.F., and Hernandez J.M. Heterogeneity of structural abnormalities in the 7q31.3∼q34 region in myeloid malignancies. Cancer Genet Cytogenet 150 (2004) 136-143
17. Michiaki K., Taizo T., Spira S., Nobuyoshi T., and Philin H. K. Allelotyping of acute myelogenous leukemia: loss of heterozygosity at 7q31.3 (D7S486) and q33-34 (D7S498, D7S505). Leukemia Res 23 (1999) 307-310
18. Zenklusen J.C., Bieche I., Lidereau R., and Conti C.J. (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc Natl Acad Sci USA 91 (1994) 12155-12158
19. Latil A., Cussenot O., Fournier G., Baron J.C., and Lidereau R. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer. Clin Cancer Res 1 (1995) 1385-1389
20. Zenklusen J.C., Thompson J.C., Klein-Szanto J.P., and Conti C.J. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1. Evidence for a broad range tumor suppressor gene. Cancer Res 55 (1995) 1347-1350
21. Zenklusen J.C., Weitzel J.N., Ball H.G., and Conti C.J. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene. Oncogene 11 (1995) 359-363
22. Gunduzl M., Ouchida M., Fukushimal K., Ito S., Jitsumori Y., Nakashima T., Nagai N., Nishizaki K., and Shimizu K. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31 in human head and neck cancers. Oncogene 21 (2002) 4462-4470
23. Zenklusen J.C., Conti C.J., and Green E.D. Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31. Nat Genet 27 (2001) 392-398
24. Cui J., Speights V.O., Maxwell T., and Brothman A.R. Hypermethylation of the caveolin-1 gene promoter in prostate cancer. Prostate 46 (2001) 249-256
25. Kohno T., Takakura S., Yamada T., Okamoto A., Tanaka T., and Yokota J. Alterations of the PPP1R3 gene in human cancer. Cancer Res 59 (1999) 4170-4174
26. Kuniyasu H., Yasui W., Yokozaki H., Akagi M., Akama Y., Kitahara K., Fujii K., and Tahara E. Frequent loss of heterozygosity of the long arm of chromosome 7 is closely associated with progression of human gastric carcinomas. Int J Cancer 59 (1994) 597-600
27. Nishizuka S., Tamura G., Terashima M., and Satodate R. Commonly deleted region on the long arm of chromosome 7 in differentiated adenocarcinoma of the stomach. Br J Cancer 76 (1997) 1567-1571
28. Takahashi S., Shan A.L., Ritland S.R., Delacey K.A., Bostwick D.G., Lieber M.M., Thibodeau S.N., and Jenkins R.B. Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res 55 (1995) 4114-4119
29. Huang H., Reed C.P., Mordi A., Lomberk G., Wang L., Shridhar V., Hartmann L., Jenkins R., and Smith D.I. Frequent deletions within FRA7G at 7q31.2 in invasive epithelial overian cancer. Genes Chromosomes Cancer 24 (1999) 48-55
30. Zhang J.S., Nelson M., McIver B., Hay I.D., Goellner J.R., Grant C.S., Eberhardt N.L., and Smith D.I. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thryroid tumors. Oncogene 17 (1998) 789-793
31. Huang H., Qian J., Proffit J., Jenkins R., and Smith D.I. FRA7G extends over a broad region: coincidence of human endogenous retroviral sequences (HERV-H) and small polydispersed circular DNAs (spcDNA) and fragile sites. Oncogene 16 (1998) 2311-2319
32. Hellman A., Zlotorynski E., Scherer S.W., Cheung J., Vincent J.B., Smith D.I., Trakhtenbrot L., and Kerem B. A role for common fragile site induction in amplication of human oncogenes. Cancer Cell 1 (2002) 89-97
33. Tatarelli C., Linnenbach A., Mimori K., and Croce C.M. Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2. Genomics 68 (2000) 1-12
34. Glukhova L., Lavialle C., Fauvet D., Chudoba I., Danglot G., Angevin E., Bernheim A., and Goguel A.F. Mapping of the 7q31 subregion common to the small chromosome 7 derivatives from two sporadic papillary renal cell carcinomas: increased copy number and overexpression of the MET proto-oncogene. Oncogene 19 (2000) 754-761
35. Michelle N., Sabina S.T., Klaus K.W., Franz B., and Peter L. Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes: MYCN, MET, WNT2, and ERBB2. GenesChromosomes Cancer 23 (1998) 307-316
36. Kuniyasu H., Yasui W., Kitadai Y., Yokozaki H., Ito H., and Tahara E. Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun 29 (1992) 443-448
37. Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 119 (1993) 265-272
38. Hyun-Ah K., Kwang-Ho K., and Ryung-Ah L. Expression of caveolin-1 is correlated with Akt-1 in colorectal cancer tissues. Exp Mol Pathol 80 (2006) 165-170